VemurafenibMeSH concept

http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-12-fra.php#zelb
2016
false
false
false
Canada
French
English
drug evaluation
risk assessment
vemurafenib
vemurafenib
melanoma
neoplasm metastasis
protein kinase inhibitors
anemia, aplastic
bone marrow
aplastic anemia secondary to chemicals
product surveillance, postmarketing
indoles
sulfonamides
Vemurafenib

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-BRAF-en-monotherapie-vemurafenib-dabrafenib-Medicaments-ciblant-BRAF-ou-MEK-en-association-vemurafenib-cobimetinib-dabrafenib-trametinib
2016
false
false
false
France
French
guidelines for drug use
practice guideline
patients guideline
protein kinase inhibitors
protein kinase inhibitors
Drug-Related side effects and adverse reactions
administration, oral
drug interactions
vemurafenib
vemurafenib
antineoplastic combined chemotherapy protocols
vemurafenib
dabrafenib
dabrafenib
dabrafenib
BRAF protein, human
Metastatic Melanoma
melanoma
melanoma
neoplasm metastasis
BRAF Gene Mutation
continuity of patient care
drug monitoring
interdisciplinary communication
protein kinase inhibitors
vemurafenib
dabrafenib
pregnancy
imidazoles
oximes
imidazoles
oximes
proto-oncogene proteins b-raf
imidazoles
oximes
indoles
sulfonamides
indoles
sulfonamides
indoles
sulfonamides
Vemurafenib
Vemurafenib
Vemurafenib

---
Skin-cancer drug Zelboraf (vemurafenib): new warning on the risk of pancreatitis
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2015/43697a-fra.php
2015
false
false
false
Canada
French
English
pancreatitis
pharmacovigilance note
vemurafenib
vemurafenib
melanoma
protein kinase inhibitors
vemurafenib
adult
protein kinase inhibitors
Drug-induced acute pancreatitis (disorder)
indoles
sulfonamides
indoles
sulfonamides
Vemurafenib
Vemurafenib

---
ZELBORAF (vemurafenib) - Risk of Radiation Sensitization or Radiation Recall Reaction
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2015/56368a-fra.php
2015
false
false
false
Canada
French
English
pharmacovigilance note
radiation injuries
melanoma
melanoma
vemurafenib
vemurafenib
radiotherapy
adult
BRAF V600E Mutation Present
chemoradiotherapy
indoles
sulfonamides
Vemurafenib

---
http://www.prescrire.org/Fr/3/31/49741/0/2014/ArchiveNewsDetails.aspx?page=1
2014
false
false
false
France
French
french abstract
neoplasm metastasis
melanoma
vemurafenib
vemurafenib
indoles
sulfonamides
Vemurafenib

---
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/38867a-fra.php
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/38869a-fra.php
2014
false
Canada
French
English
vemurafenib
vemurafenib
Chemical and Drug Induced Liver Injury
continuity of patient care
pharmacovigilance note
Chemical and Drug Induced Liver Injury
melanoma
indoles
sulfonamides
Vemurafenib

---
http://www.meddispar.fr/Medicaments/ZELBORAF-240-B-56/(type)/letter/(value)/Z/(cip)/3400922087566
2013
false
France
French
drug information
administration, oral
legislation, drug
drug prescriptions
vemurafenib
vemurafenib
continuity of patient care
indoles
sulfonamides
Vemurafenib

---
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/35165a-fra.php
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/35171a-fra.php
2013
false
Canada
English
French
drug hypersensitivity syndrome
vemurafenib
vemurafenib
neoplasms
disease progression
canada
eosinophilia
protein kinase inhibitors
pharmacovigilance note
genes, ras
patient education handout
indoles
sulfonamides
Vemurafenib

---
http://www.has-sante.fr/portail/jcms/c_1355322/zelboraf-vemurafenib-inhibiteur-de-la-proteine-kinase-braf
http://www.has-sante.fr/portail/jcms/c_1355321/zelboraf-synthese-ct12121
2012
France
French
melanoma
evaluation of the transparency committee
guidelines for drug use
vemurafenib
indoles
sulfonamides
proto-oncogene proteins b-raf
Vemurafenib

---
http://www.has-sante.fr/portail/jcms/c_1329823/zelboraf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/zelboraf_03102012_avis_ct12121.pdf
2012
false
France
French
administration, oral
insurance, health, reimbursement
evaluation of the transparency committee
vemurafenib
vemurafenib
vemurafenib
protein kinase inhibitors
protein kinase inhibitors
adult
neoplasm metastasis
melanoma
indoles
indoles
sulfonamides
sulfonamides
Vemurafenib
Vemurafenib

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66271123
2012
France
summary of product characteristics
tablets
vemurafenib

---
https://www.ema.europa.eu/medicines/human/EPAR/Zelboraf
2012
false
United Kingdom
French
English
syndication feed
indoles
indoles
sulfonamides
sulfonamides
administration, oral
protein kinase inhibitors
protein kinase inhibitors
vemurafenib
melanoma
BRAF protein, human
proto-oncogene proteins b-raf
vemurafenib
vemurafenib
drug approval
adult
treatment outcome
melanoma
neoplasm metastasis
drug interactions
pregnancy
breast feeding
proto-oncogene proteins b-raf
mutation
clinical trials, phase iii as topic
survival analysis
clinical trials, phase ii as topic
drug evaluation, preclinical
drug evaluation
summary of product characteristics
package leaflet
Vemurafenib
Vemurafenib

---